-
Mashup Score: 2Dr. Ramalingam Discusses How LAURA Established a 'New Standard of Care' | Docwire News - 8 month(s) ago
The Two Onc Docs joined us at the 2024 American Society of Clinical Oncology Annual Meeting to interview Suresh S. Ramalingam, MD, FACP, FASCO, about his plenary presentation on the practice-changing LAURA study. The trio unpacked the data, the trial design, and what the LAURA study means for the future of oncology during a must-watch video interview.
Tweet
-
Mashup Score: 13Dr. Balazs Halmos on Using Major Lung Cancer Updates to Inform Community Practice | Docwire News - 8 month(s) ago
We were thrilled to have Balazs Halmos, MD, stop by at #ASCOLung to share his insights on the historic updates in thoracic oncology from the meeting and how community oncologists can put those into practice. If you’re catching up on #ASCO24 data before WCLC, don’t miss this video!
Tweet-
🫁 Thanks to @DrSteveMartin for stopping by to chat with us at #ASCO24 about key #ASCOLung highlights!🌟 Don't miss this interview, which features his insights on translating major lung cancer updates into practice: https://t.co/tyFzDPy8CI😀Stay tuned for more! https://t.co/1yKiASebiF
-
-
Mashup Score: 4
Lung Cancers Today brought together an amazing panel of experts at #ASCO24 to discuss challenges, progress, and new clinical trial data on non-small cell lung cancer. In this video from the discussion, the experts share what they’re seeing in their practices in terms of lung cancer screening and the prevalence of metastatic disease at diagnosis.
Tweet-
🫁 What are the challenges & unmet needs surrounding lung cancer screening?🎙️ @DasMillie11, @LealTiciana, @DoctorDietrich, and Kent Shih, MD, share their experiences & insights in the first video of our new #NSCLC roundtable series.➡️ Watch now: https://t.co/aOGkeiHYPg#lcsm https://t.co/gK37xGEILB
-
-
Mashup Score: 1Panel Discusses How to Talk to Patients About Starting Lung Cancer Treatment | Docwire News - 8 month(s) ago
In this segment of our roundtable on non-small cell lung cancer, the panelists address an especially pressing question in the era of targeted therapies: What do you do while awaiting NGS testing results for patients with lung cancer? Hear what the experts are doing in their practices!
Tweet-
🧬 What do you do about treatment while awaiting NGS testing results for patients with NSCLC?🎙️ Hear insights and strategies from @DasMillie11, @LealTiciana, @DoctorDietrich, and Kent Shih, MD, in our new #NSCLC roundtable series.➡️ Watch now: https://t.co/u9Rs4GPLDx #lcsm https://t.co/n79Cm5y7Tl
-
-
Mashup Score: 15
With WCLC fast approaching, it’s a great time to review the pivotal data from #ASCO24 to set the stage for the next wave of developments in thoracic oncology. Check out our interview with Rami Manochakian, MD, FASCO, who shares his insights on translating the key takeaways from #ASCOLung
Tweet-
🫁 Catching up on #ASCOLung news before #WCLC24 kicks off in a few weeks?⭐ Don't miss this insightful interview with @RManochakian, who shared key updates from #ASCO24 at the @OncBrothers Advancements in Oncology event.➡️ Watch now: https://t.co/rTeZrGS3Iv https://t.co/Ue98Ie2dtq
-
🗨️ What are the clinical implications of the practice-changing #LAURA study?🌟 In this video, the @TwoOncDocs interview @RamalingamMD about his plenary presentation on the phase 3 trial during #ASCO24! ➡️ Watch now: https://t.co/wW4NdkNWit#NSCLC #lcsm #ASCOLung https://t.co/pGr0aW1bDi